Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Galmed Pharmaceutica (GLMD)

Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? Motley Fool - Sun Mar 17, 4:50AM CDT

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

GALT : 3.29 (-2.66%)
GLMD : 0.4000 (+10.68%)
VKTX : 65.07 (+0.22%)
ETNB : 8.58 (-3.81%)
IVA : 3.24 (-1.52%)
SGMT : 4.17 (-2.57%)
TERN : 4.75 (+1.28%)
NVO : 126.16 (-1.93%)
IQV : 240.84 (+0.93%)
MDGL : 204.65 (-6.29%)
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis PR Newswire - Tue Sep 26, 2023

/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...

GLMD : 0.4000 (+10.68%)
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire - Fri Sep 22, 2023

/PRNewswire/ —Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...

GLMD : 0.4000 (+10.68%)
Galmed Pharmaceuticals: Q2 Earnings Snapshot AP - Thu Aug 10, 2023

Galmed Pharmaceuticals: Q2 Earnings Snapshot

GLMD : 0.4000 (+10.68%)
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering PR Newswire - Fri Jul 14, 2023

/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...

GLMD : 0.4000 (+10.68%)
Galmed to employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSC PR Newswire - Mon Jul 10, 2023

/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...

GLMD : 0.4000 (+10.68%)
Galmed Pharmaceuticals: Q1 Earnings Snapshot AP - Thu Jun 1, 2023

Galmed Pharmaceuticals: Q1 Earnings Snapshot

GLMD : 0.4000 (+10.68%)
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022 PR Newswire - Wed Mar 29, 2023

/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...

GLMD : 0.4000 (+10.68%)
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement PR Newswire - Wed Dec 14, 2022

/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a biopharmaceutical company focused on the development of Aramchol and...

GLMD : 0.4000 (+10.68%)
Galmed Pharmaceuticals: Q3 Earnings Snapshot AP - Thu Nov 17, 2022

Galmed Pharmaceuticals: Q3 Earnings Snapshot

GLMD : 0.4000 (+10.68%)

Barchart Exclusives

3 Dividend Aristocrats to Buy on Every Dip Barchart - 56 minutes ago
As markets get wobbly, here are three Dividend Aristocrats to add a little stability to any portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot